X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with BAJAJ CORP - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BAJAJ CORP - Comparison Results

BAJAJ CORP 
   Change

Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BAJAJ CORP AMAR REMEDIES/
BAJAJ CORP
 
P/E (TTM) x -0.5 33.2 - View Chart
P/BV x 0.1 14.5 0.4% View Chart
Dividend Yield % 0.0 2.4 -  

Financials

 AMAR REMEDIES   BAJAJ CORP
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BAJAJ CORP
Mar-17
AMAR REMEDIES/
BAJAJ CORP
5-Yr Chart
Click to enlarge
High Rs164438 37.4%   
Low Rs86340 25.3%   
Sales per share (Unadj.) Rs261.654.0 484.2%  
Earnings per share (Unadj.) Rs17.414.8 117.6%  
Cash flow per share (Unadj.) Rs22.315.2 147.0%  
Dividends per share (Unadj.) Rs011.50 0.0%  
Dividend yield (eoy) %03.0 0.0%  
Book value per share (Unadj.) Rs100.733.5 300.6%  
Shares outstanding (eoy) m26.16147.50 17.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.2 6.6%   
Avg P/E ratio x7.226.3 27.3%  
P/CF ratio (eoy) x5.625.7 21.8%  
Price / Book Value ratio x1.211.6 10.7%  
Dividend payout %077.7 0.0%   
Avg Mkt Cap Rs m3,27057,400 5.7%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m163614 26.6%   
Avg. sales/employee Rs ThNM15,208.0-  
Avg. wages/employee Rs ThNM1,171.6-  
Avg. net profit/employee Rs ThNM4,164.9-  
INCOME DATA
Net Sales Rs m6,8447,969 85.9%  
Other income Rs m21394 5.3%   
Total revenues Rs m6,8658,363 82.1%   
Gross profit Rs m1,1312,636 42.9%  
Depreciation Rs m12853 240.6%   
Interest Rs m39810 3,864.1%   
Profit before tax Rs m6262,966 21.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-184 27.2%   
Tax Rs m121600 20.2%   
Profit after tax Rs m4552,182 20.8%  
Gross profit margin %16.533.1 50.0%  
Effective tax rate %19.320.2 95.5%   
Net profit margin %6.627.4 24.3%  
BALANCE SHEET DATA
Current assets Rs m4,9044,259 115.2%   
Current liabilities Rs m3,581788 454.4%   
Net working cap to sales %19.343.6 44.4%  
Current ratio x1.45.4 25.3%  
Inventory Days Days12419 638.7%  
Debtors Days Days10013 797.2%  
Net fixed assets Rs m1,6891,616 104.5%   
Share capital Rs m262148 177.6%   
"Free" reserves Rs m2,3584,794 49.2%   
Net worth Rs m2,6354,942 53.3%   
Long term debt Rs m5070-   
Total assets Rs m6,8625,895 116.4%  
Interest coverage x2.6289.0 0.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 73.8%   
Return on assets %12.437.2 33.4%  
Return on equity %17.344.2 39.1%  
Return on capital %31.056.5 54.9%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27330 925.4%   
Fx outflow Rs m27 29.9%   
Net fx Rs m27123 1,188.6%   
CASH FLOW
From Operations Rs m-3132,120 -14.7%  
From Investments Rs m-489-153 318.4%  
From Financial Activity Rs m769-2,000 -38.4%  
Net Cashflow Rs m-33-33 98.2%  

Share Holding

Indian Promoters % 25.5 66.9 38.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 1.6 564.4%  
FIIs % 0.0 24.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 7.1 919.7%  
Shareholders   13,061 19,219 68.0%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   ARCHIES LTD  MARICO LTD  GODREJ INDUSTRIES  LINC PEN & PLASTICS LTD  GILLETTE INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS